Table 1 Risk factor analysis of the occurrence of IKPLAS

 Age

1.040

1.002–1.080

0.041

1.010

0.956–1.068

0.716

 Gender: male

1.311

0.493–3.485

0.587

 Diabetes mellitus

3.651

1.266–10.53

0.017

2.172

0.466–10.112

0.323

 Hypertension

1.683

0.630–4.491

0.299

 Coronary heart disease

0.607

0.103–3.563

0.580

 Chronic liver diseases

2.327

0.672–8.060

0.183

 Chronic kidney diseases

0.821

0.209–3.219

0.777

 Biliary tract disease

0.381

0.071–2.041

0.260

 WBC (10⁹/L)

0.982

0.868–1.112

0.776

 CRP (mg/L)

1.005

0.996–1.013

0.278

 Neu (%)

0.998

0.963–1.035

0.910

 Hb (g/L)

0.990

0.965–1.016

0.435

 AST (U/L)

1.002

0.980–1.025

0.843

 ALT (U/L)

1.003

0.985–1.021

0.747

 HbA1c

1.527

1.054–2.211

0.025

 PCT (ng/mL)

1.014

0.971–1.058

0.529

 Lactate (mmol/L)

3.210

1.485–6.937

0.003

4.547

1.488–13.89

0.008

 PT (s)

0.938

0.621–1.418

0.761

 APTT (s)

1.003

0.896–1.123

0.955

Abscess size (cm)

1.138

0.926–1.399

0.219

 Cephalosporins

4th gen

0.571

0.217–1.503

0.256

 Fluoroquinolones

levofloxacin

0.797

0.290–2.188

0.660

moxifloxacin

0.137

0.035–0.531

0.004

0.087

0.009–0.875

0.038

 Carbapenems

imipenem

0.496

0.136–1.803

0.287

meropenem

0.607

0.103–3.563

0.580

 Metronidazole

0.431

0.120–1.544

0.196

 Cephamycins

1.795

0.369–8.719

0.468

 Aztreonam

0.733

0.161–3.350

0.689

Number of puncture

3.511

1.406–8.770

0.007

3.050

1.172–7.937

0.022

length of stay

1.028

0.981–1.077

0.247